Metraipolis › archive › dc_09c6df2b52bb
Systemic immunologic effects of long-term dupilumab treatment in severe eosinophilic asthma beyond clinical outcomes — Europe PMC PMID:42440605
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42440605
- DOI
- 10.3389/falgy.2026.1873964
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T07:07:45.114Z
- SHA-256 of the archived text
ff0a59dc133c7737692abd2a71815f756cde48ab29d617db9b35382a1c1de7c0- Stable URL of this page
https://metraipolis.com/documento/dc_09c6df2b52bb
How to cite
Systemic immunologic effects of long-term dupilumab treatment in severe eosinophilic asthma beyond clinical outcomes — Europe PMC PMID:42440605 — Europe PMC (en), https://europepmc.org/article/MED/42440605 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_09c6df2b52bb (Metraipolis archive dc_09c6df2b52bb, sha256 ff0a59dc133c7737692abd2a71815f756cde48ab29d617db9b35382a1c1de7c0)
BibTeX
@misc{dc09c6df2b52bb,
title = {Systemic immunologic effects of long-term dupilumab treatment in severe eosinophilic asthma beyond clinical outcomes — Europe PMC PMID:42440605},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42440605},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_09c6df2b52bb; sha256 ff0a59dc133c7737692abd2a71815f756cde48ab29d617db9b35382a1c1de7c0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42440605. Agents can read the archived copy with the MCP tool read_document.